Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Long-Term Efficacy of Clobazam for Drop Attacks in Lennox-Gastaut Syndrome Is Consistent Across Patient Age Ranges
Epilepsy/Clinical Neurophysiology (EEG)
(-)
249
Authors/Disclosures
Jouko I. Isojarvi, MD, PhD (Lundbeck)
PRESENTER
No disclosure on file
Deborah A. Lee, MD, PhD (AlaWai Neurology Consulting LLC) No disclosure on file
Vivienne Shen Vivienne Shen has received personal compensation for serving as an employee of Lundbeck.
Jeffrey R. Buchhalter, MD, FÂé¶¹´«Ã½Ó³»­ (Buchhalter Consulting PLLC) Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Buchhalter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona.
Brian D. Moseley, MD Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.